Chronology of patulin-induced alterations in membrane function of cultured renal cells, LLC-PK.
In a previous study we compared the effects of patulin (PAT) and ouabain, a specific inhibitor of the Na(+)-K+ ATPase, and found significant differences with regard to the kinetics of Na+ influx and K+ efflux, and sulfhydryl reactivity in LLC-PK1 cells. The purpose of the present study was to determine the relationship between Na+ influx, K+ efflux, membrane potential ([3H]tetraphenylphosphonium accumulation), cellular viability [lactate dehydrogenase (LDH) release], and changes in cell morphology (blebs). The effects of PAT are concentration and time dependent. At concentrations of PAT above 10 microM there is a transient increase in intracellular electronegativity (less than 1 hr) followed by a sustained depolarization (greater than 1 hr) which is correlated with complete Na+ influx, K+ efflux, total LDH release, and bleb formation. However, at PAT concentrations of 5-10 microM there is a sustained increased intracellular electronegativity (4-8 hr) which is associated with partial Na+ influx and K+ efflux, no significant LDH release, and relatively few blebs. The hyperpolarizing effect may be a result of increased permeability to K+ relative to Na+. At times and concentrations which result in increased intracellular electronegativity, PAT has no effect on [3H]ouabain binding and thus increased Na+/K+ pump turnover does not seem to be the cause of the transient hyperpolarizing effect of PAT. These results are consistent with the hypothesis that PAT causes alterations in plasma membrane permeability which favor K+ efflux relative to Na+ influx. The toxic effects of PAT are irreversible in LLC-PK1 cells after even short pretreatment with PAT. The primary toxic lesion appears to be at some level other than that involving inhibition of macromolecular synthesis, perhaps the plasma membrane itself.
Riley
R T
RT
Russell Research Center, United States Department of Agriculture, Athens, Georgia 30613.
Hinton
D M
DM
Showker
J L
JL
Rigsby
W
W
Norred
W P
WP
D000818:Animals; D002460:Cell Line / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004577:Electron Probe Microanalysis; D007202:Indicators and Reagents; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D009861:Onium Compounds / Q000493:pharmacokinetics; D009943:Organophosphorus Compounds / Q000493:pharmacokinetics; D010042:Ouabain / Q000493:pharmacokinetics / Q000494:pharmacology; D010365:Patulin / Q000633:toxicity*; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism; D011714:Pyrans / Q000633:toxicity*; D011817:Rabbits; D015222:Sodium Channels / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors
D007202:Indicators and Reagents; D009861:Onium Compounds; D009943:Organophosphorus Compounds; D015221:Potassium Channels; D011714:Pyrans; D015222:Sodium Channels; D010042:Ouabain; D010365:Patulin; D007770:L-Lactate Dehydrogenase; C013289:tetraphenylphosphonium